Contraception and Abortion Care for People Living With HIV: A Clinical Guide for Reproductive Health Practitioners.
Lanbo Yang, Rebecca H Allen, Mary Catherine Cambou and 2 others
PMID 37903728WHAT IT FOUND
Contraception and abortion care are often possible for people living with HIV, but efavirenz may reduce implant effectiveness.
Check HIV drug interactions before choosing a method.
Key findings
01Copper IUDs are not associated with increased HIV infection, and levonorgestrel IUDs are not associated with increased pelvic inflammatory disease or changes in genital tract or plasma HIV viral load compared with copper IUDs.
02Efavirenz combined with a progestin implant has been reported to lower progestin levels by as much as 40% to 82%, with increased contraceptive failure, although newer cohort data question this.
03Abortion evidence in people living with HIV is limited: a small medication-abortion case series of 68 women not on antiretroviral therapy reported 96% efficacy and low complications with mifepristone and misoprostol, and procedural-abortion studies did not clearly show increased infection risk.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a clinical guide/review, not a trial of contraception or abortion care, so its recommendations are expert synthesis rather than tested treatment effects. Most cited evidence is from small studies of drug levels, patient groups, or case reports, and many drug-interaction findings have not been linked to real pregnancy or safety outcomes. The largest medication-abortion study cited included 68 women living with HIV who were not on antiretroviral therapy, so it does not answer safety for patients on current HIV treatment. Procedural-abortion studies had small samples and mixed antiretroviral use, so it is hard to attribute complications to HIV alone. The review uses gender criteria from original studies and notes findings may not apply to gender-diverse people capable of pregnancy.
Declared interests
One author previously received research support from Bayer A.G. and is a consultant to Merck & Co.; the supplied text declares no other conflicts.
The easy way to misread this
Do not read this as proof that a contraceptive or abortion method works for every person living with HIV. It is a clinical guide built from limited studies, and efavirenz may lower implant hormone levels enough to increase contraceptive failure.